We proposed a set of 9 criteria to evaluate computerized French drug d
ata banks currently available on the Minitel, medical software, or the
Web. These criteria are used for testing the scientific quality of th
e information provided in terms of reliability and completeness. They
round off the nine criteria proposed in a previous study for sole drug
interactions. None of the drug data banks is better than the others o
n all the selected dimensions. But the methodology presented should al
low a particular user with defined needs to weigh up the criteria and
optimize his choice.